I've found that ARQT has solid FDA wins and impressive clinical trial results, which indicate substantial growth potential. With a tiny market cap rel...
Read
More
I've found that ARQT has solid FDA wins and impressive clinical trial results, which indicate substantial growth potential. With a tiny market cap relative to its total addressable market, I believe this stock could see significant upside as it pushes for additional approvals in the skincare sector.